Mario Delgado

12PUBLICATIONS
41CO-AUTHORS
Pharmaceutical delivery technologiesPharmacogenomicsNeurology and neuromuscular diseasesBiologically active moleculesEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 23, 2024
Cortistatin as a Novel Multimodal Therapy for the Treatment of Parkinson's Disease.

Ignacio Serrano-Martínez, Marta Pedreño, Julia Castillo-González

|Jan 09, 2024
A potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells.

Yahaira Naaldijk, Belén Fernández, Rachel Fasiczka

|Sep 28, 2023
Novel Therapeutic Opportunities for Neurodegenerative Diseases with Mesenchymal Stem Cells: The Focus on Modulating the Blood-Brain Barrier.

Pablo Vargas-Rodríguez, Alejandro Cuenca-Martagón, Julia Castillo-González

|Dec 23, 2022
Therapeutic Effect of a Latent Form of Cortistatin in Experimental Inflammatory and Fibrotic Disorders.

Jenny Campos-Salinas, Margarita Barriga, Mario Delgado

|Jul 27, 2022
Efficacy of Vafidemstat in Experimental Autoimmune Encephalomyelitis Highlights the KDM1A/RCOR1/HDAC Epigenetic Axis in Multiple Sclerosis.

Fernando Cavalcanti, Elena Gonzalez-Rey, Mario Delgado

|Feb 25, 2022
Switching Roles: Beneficial Effects of Adipose Tissue-Derived Mesenchymal Stem Cells on Microglia and Their Implication in Neurodegenerative Diseases.

Ana Isabel Sánchez-Castillo, M Rosario Sepúlveda, José Luis Marín-Teva

Pageof 2

Frequent Collaborators

5 joint publications

Elena Gonzalez-Rey

3 joint publications

Francisco O'Valle

2 joint publications

Ignacio Serrano-Martínez

2 joint publications

Pablo Vargas-Rodríguez